Literature DB >> 25547684

Generation of hepatitis B virus PreS2-S antigen in Hansenula polymorpha.

Xiaowei Xu1, Sulin Ren, Xiaoxiao Chen, Jun Ge, Zhenxing Xu, Hongying Huang, Honglin Sun, Yue Gu, Tong Zhou, Jianqiang Li, Hanmei Xu.   

Abstract

Despite the long availability of a traditional prophylactic vaccine containing the HBV surface antigen (HBsAg) and aluminum adjuvant, nearly 10% of the population remains unable to generate an effective immune response. Previous studies have indicated that hepatitis B virus (HBV) PreS2-S is abundant in T/B cell epitopes, which induces a stronger immune response than HBsAg, particularly in terms of cytotoxic T lymphocyte (CTL) reaction. In the current study, the HBV PreS2-S gene encoding an extra 26 amino acids (PreS2 C-terminus) located at the N-terminus of HBsAg was cloned into the pVCH1300 expression vector. PreS2-S expressed in the methylotrophic yeast, Hansenula polymorpha, was produced at a yield of up to 250 mg/L. Subsequent purification steps involved hydrophobic adsorption to colloidal silica, ion-exchange chromatography and density ultracentrifugation. The final product was obtained with a total yield of ∼ 15% and purity of ∼ 99%. In keeping with previous studies, ∼ 22 nm viruslike particles were detected using electron microscopy. The generated PreS2-S antigen will be further studied for efficacy and safty in animals.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25547684      PMCID: PMC8206452          DOI: 10.1007/s12250-014-3508-9

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  17 in total

1.  Solution conformation of an immunodominant epitope in the hepatitis B virus preS2 surface antigen.

Authors:  Seung-Wook Chi; Do-Hyoung Kim; Jae-Sung Kim; Myung Kyu Lee; Kyou-Hoon Han
Journal:  Antiviral Res       Date:  2006-07-07       Impact factor: 5.970

2.  Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris.

Authors:  E Hardy; E Martínez; D Diago; R Díaz; D González; L Herrera
Journal:  J Biotechnol       Date:  2000-02-17       Impact factor: 3.307

3.  Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen.

Authors:  D R Milich; G B Thornton; A R Neurath; S B Kent; M L Michel; P Tiollais; F V Chisari
Journal:  Science       Date:  1985-06-07       Impact factor: 47.728

4.  Highly-efficient electrotransformation of the yeast Hansenula polymorpha.

Authors:  K N Faber; P Haima; W Harder; M Veenhuis; G AB
Journal:  Curr Genet       Date:  1994-04       Impact factor: 3.886

5.  Identification of the critical regions in hepatitis B virus preS required for its stability.

Authors:  Min Lian; Xu Zhou; Bin Chen; Chan Li; Xiaocheng Gu; Ming Luo; Xiaofeng Zheng
Journal:  J Pept Sci       Date:  2008-03       Impact factor: 1.905

6.  High-level expression of foreign genes in Hansenula polymorpha.

Authors:  G Gellissen; Z A Janowicz; U Weydemann; K Melber; A W Strasser; C P Hollenberg
Journal:  Biotechnol Adv       Date:  1992       Impact factor: 14.227

7.  Characterization of purified hepatitis B surface antigen containing pre-S(2) epitopes expressed in Saccharomyces cerevisiae.

Authors:  K E Langley; K M Egan; J M Barendt; C G Parker; G A Bitter
Journal:  Gene       Date:  1988-07-30       Impact factor: 3.688

8.  Induction of protection level of anti-pre-S2 antibodies in humans immunized with a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine).

Authors:  S Kuroda; Y Fujisawa; S Iino; Y Akahane; H Suzuki
Journal:  Vaccine       Date:  1991-03       Impact factor: 3.641

Review 9.  Occult hepatitis B.

Authors:  Michael Torbenson; David L Thomas
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

10.  Expression of HBsAg and preS2-S protein in different yeast based system: a comparative analysis.

Authors:  Nadia Hadiji-Abbes; Istabrak Borchani-Chabchoub; Henda Triki; Radhouane Ellouz; Ali Gargouri; Raja Mokdad-Gargouri
Journal:  Protein Expr Purif       Date:  2009-03-20       Impact factor: 1.650

View more
  3 in total

Review 1.  Customized yeast cell factories for biopharmaceuticals: from cell engineering to process scale up.

Authors:  Aravind Madhavan; K B Arun; Raveendran Sindhu; Jayaram Krishnamoorthy; R Reshmy; Ranjna Sirohi; Arivalagan Pugazhendi; Mukesh Kumar Awasthi; George Szakacs; Parameswaran Binod
Journal:  Microb Cell Fact       Date:  2021-06-30       Impact factor: 5.328

Review 2.  Sneaking Out for Happy Hour: Yeast-Based Approaches to Explore and Modulate Immune Response and Immune Evasion.

Authors:  Gaëlle Angrand; Alicia Quillévéré; Nadège Loaëc; Chrysoula Daskalogianni; Anton Granzhan; Marie-Paule Teulade-Fichou; Robin Fahraeus; Rodrigo Prado Martins; Marc Blondel
Journal:  Genes (Basel)       Date:  2019-08-31       Impact factor: 4.096

3.  Efficient CRISPR-Cas9 mediated multiplex genome editing in yeasts.

Authors:  Laiyou Wang; Aihua Deng; Yun Zhang; Shuwen Liu; Yong Liang; Hua Bai; Di Cui; Qidi Qiu; Xiuling Shang; Zhao Yang; Xiuping He; Tingyi Wen
Journal:  Biotechnol Biofuels       Date:  2018-10-10       Impact factor: 6.040

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.